-
Pfizer acquires Bamboo Therapeutics
NEW YORK — In a move aimed at bolstering its position in the gene therapy field, Pfizer on Monday announced its acquisition of Bamboo Therapeutics. The Chapel Hill, N.C.-based company focuses on developing gene therapies for patients with rare diseases related to neuromuscular and central nervous system conditions.FDA approves ACE inhibitor oral solution Qbrelis
SILVER SPRING, Md. — The Food and Drug Administration has approved Silvergate Pharmaceuticals’ Qbrelis (lisinopril) oral solution, the company announced Friday. Qbrelis is the first and only FDA-approved oral solution of the ACE inhibitor lisinopril indicated to treat hypertension in adults and pediatric patients 6 years of age and older, the company said.